Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac injection site comparison after impacted third molar surgery
IRCT20130812014333N155Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ketorolac in impacted third molar (I3M) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Pain intensity, Trismus and 1 more. Started Oct 2020; status: completed.
02
Drugs
ketorolac
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on IRCT20130812014333N155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N155.